301 related articles for article (PubMed ID: 35333951)
1. The role of serotonin neurotransmission in rapid antidepressant actions.
Pehrson AL; Roberts D; Khawaja A; McNair R
Psychopharmacology (Berl); 2022 Jun; 239(6):1823-1838. PubMed ID: 35333951
[TBL] [Abstract][Full Text] [Related]
2. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of ketamine action as an antidepressant.
Zanos P; Gould TD
Mol Psychiatry; 2018 Apr; 23(4):801-811. PubMed ID: 29532791
[TBL] [Abstract][Full Text] [Related]
4. The role of eEF2 kinase in the rapid antidepressant actions of ketamine.
Suzuki K; Monteggia LM
Adv Pharmacol; 2020; 89():79-99. PubMed ID: 32616215
[TBL] [Abstract][Full Text] [Related]
5. The potential benefit of combined versus monotherapy of coenzyme Q10 and fluoxetine on depressive-like behaviors and intermediates coupled to Gsk-3β in rats.
Abuelezz SA; Hendawy N; Magdy Y
Toxicol Appl Pharmacol; 2018 Feb; 340():39-48. PubMed ID: 29291430
[TBL] [Abstract][Full Text] [Related]
6. Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics.
Kojic M; Saelens J; Kadriu B; Zarate CA; Kraus C
Curr Top Behav Neurosci; 2022; 56():141-167. PubMed ID: 35312993
[TBL] [Abstract][Full Text] [Related]
7. Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT
Fukumoto K; Fogaça MV; Liu RJ; Duman CH; Li XY; Chaki S; Duman RS
Neuropsychopharmacology; 2020 Sep; 45(10):1725-1734. PubMed ID: 32396921
[TBL] [Abstract][Full Text] [Related]
8. Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine.
Chaki S; Fukumoto K
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871246
[TBL] [Abstract][Full Text] [Related]
9. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
[TBL] [Abstract][Full Text] [Related]
10. Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.
Kim JW; Monteggia LM
Behav Brain Res; 2020 Feb; 380():112378. PubMed ID: 31760154
[TBL] [Abstract][Full Text] [Related]
11. New investigational agents for the treatment of major depressive disorder.
Pochwat B; Krupa AJ; Siwek M; Szewczyk B
Expert Opin Investig Drugs; 2022 Oct; 31(10):1053-1066. PubMed ID: 35975761
[TBL] [Abstract][Full Text] [Related]
12. Recent Developments on Future Antidepressant-related Serotonin Receptors.
Amidfar M; Kim YK
Curr Pharm Des; 2018; 24(22):2541-2548. PubMed ID: 30073919
[TBL] [Abstract][Full Text] [Related]
13. Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine.
López-Gil X; Jiménez-Sánchez L; Campa L; Castro E; Frago C; Adell A
ACS Chem Neurosci; 2019 Jul; 10(7):3318-3326. PubMed ID: 31244055
[TBL] [Abstract][Full Text] [Related]
14. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
[TBL] [Abstract][Full Text] [Related]
15. Synaptic mechanisms underlying rapid antidepressant action of ketamine.
Kavalali ET; Monteggia LM
Am J Psychiatry; 2012 Nov; 169(11):1150-6. PubMed ID: 23534055
[TBL] [Abstract][Full Text] [Related]
16. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.
Liu RJ; Fuchikami M; Dwyer JM; Lepack AE; Duman RS; Aghajanian GK
Neuropsychopharmacology; 2013 Oct; 38(11):2268-77. PubMed ID: 23680942
[TBL] [Abstract][Full Text] [Related]
17. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2
Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184
[TBL] [Abstract][Full Text] [Related]
18. Gene expression related to serotonergic and glutamatergic neurotransmission is altered in the flinders sensitive line rat model of depression: Effect of ketamine.
Du Jardin KG; Müller HK; Sanchez C; Wegener G; Elfving B
Synapse; 2017 Jan; 71(1):37-45. PubMed ID: 27589698
[TBL] [Abstract][Full Text] [Related]
19. A possible mechanism of the nucleus accumbens and ventral pallidum 5-HT1B receptors underlying the antidepressant action of ketamine: a PET study with macaques.
Yamanaka H; Yokoyama C; Mizuma H; Kurai S; Finnema SJ; Halldin C; Doi H; Onoe H
Transl Psychiatry; 2014 Jan; 4(1):e342. PubMed ID: 24399045
[TBL] [Abstract][Full Text] [Related]
20. Neurobiology of rapid acting antidepressants: role of BDNF and GSK-3β.
Duman RS; Aghajanian GK
Neuropsychopharmacology; 2014 Jan; 39(1):233. PubMed ID: 24317309
[No Abstract] [Full Text] [Related]
[Next] [New Search]
